Weight Loss / Metabolic
Tirzepatide GLP-2 — 30mg
Dual Agonist (GLP-1/GIP)
$168/month
Vial Size
Tirzepatide is a first-in-class dual incretin agonist targeting both GLP-1 and GIP receptors for superior appetite control and metabolic improvement.
Key Benefits
Dual receptor action
Superior appetite control
Improved insulin sensitivity
Sustainable weight loss
Related Products
Ready to start with Tirzepatide GLP-2?
Take our eligibility quiz to see if this treatment is right for you.
